Abstract
Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have